Use of crystal forms of 2-methyl-thieno-benzodiazepine

Use of substantially pure Form II olanzapine polymorph for the manufacture of a medicament for the treatment of schizophrenia, schizophreniform disorders, psychosis, mild anxiety states, functional bowel disorders, or acute mania.

Saved in:
Bibliographic Details
Main Authors LARSEN, SAMUEL DEAN, HENDRIKSEN, BARRY ARNOLD, BUNNELL, CHARLES ARTHUR
Format Patent
LanguageEnglish
French
German
Published 11.08.2004
Edition7
Subjects
APPARATUS THEREFOR
CHEMISTRY
GENERAL METHODS OF ORGANIC CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Use of substantially pure Form II olanzapine polymorph for the manufacture of a medicament for the treatment of schizophrenia, schizophreniform disorders, psychosis, mild anxiety states, functional bowel disorders, or acute mania.
Bibliography:Application Number: EP20030077455